These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22940761)

  • 1. Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates.
    Leak RK; Garbett KA; Dettmer AM; Zhang Z; Mirnics K; Cameron JL
    Cell Tissue Res; 2012 Dec; 350(3):401-7. PubMed ID: 22940761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease.
    Pifl C; Nanoff C; Schingnitz G; Schütz W; Hornykiewicz O
    J Neurochem; 1992 Jun; 58(6):1997-2004. PubMed ID: 1349341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.
    Pifl C; Hornykiewicz O
    Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease.
    Pifl C; Schingnitz G; Hornykiewicz O
    Neurosci Lett; 1988 Oct; 92(2):228-33. PubMed ID: 3263594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
    Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
    Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates.
    Soghomonian JJ; Pedneault S; Audet G; Parent A
    J Neurosci; 1994 Oct; 14(10):6256-65. PubMed ID: 7931578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys.
    Villalba RM; Lee H; Smith Y
    Exp Neurol; 2009 Feb; 215(2):220-7. PubMed ID: 18977221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPTP-induced parkinsonism in primates: pattern of striatal dopamine loss following acute and chronic administration.
    Pérez-Otaño I; Oset C; Luquin MR; Herrero MT; Obeso JA; Del Río J
    Neurosci Lett; 1994 Jul; 175(1-2):121-5. PubMed ID: 7970192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
    J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET studies of functional compensation in a primate model of Parkinson's disease.
    Eberling JL; Bankiewicz KS; Jordan S; VanBrocklin HF; Jagust WJ
    Neuroreport; 1997 Aug; 8(12):2727-33. PubMed ID: 9295108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective metabolic activation by apomorphine in striosomes of denervated striatum in MPTP-induced hemiparkinsonian monkeys.
    Pontieri FE; Viola JJ; Sokoloff L; Porrino LJ
    Neuroreport; 1995 Jun; 6(9):1330-2. PubMed ID: 7669997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.
    Quik M; Parameswaran N; McCallum SE; Bordia T; Bao S; McCormack A; Kim A; Tyndale RF; Langston JW; Di Monte DA
    J Neurochem; 2006 Sep; 98(6):1866-75. PubMed ID: 16882311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.